Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1984-04-11
1986-07-15
Schenkman, Leonard
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514376, 514389, 514409, 514866, A61K 3144, A61K 31415
Patent
active
046007172
ABSTRACT:
Method of promoting healing of ocular wounds comprising the topical application of an aldose reductase inhibitor; compositions comprising such inhibitors are also disclosed.
REFERENCES:
patent: 3821383 (1974-06-01), Sestanj et al.
patent: 4117230 (1978-09-01), Sarges
patent: 4130714 (1978-12-01), Sarges
patent: 4181728 (1980-01-01), Sarges et al.
patent: 4436745 (1984-03-01), York, Jr.
patent: 4438272 (1984-03-01), York, Jr.
Alcon Laboratories Inc.
Schenkman Leonard
LandOfFree
Aldose reductase inhibitors useful in ophthalmic wound healing does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Aldose reductase inhibitors useful in ophthalmic wound healing, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Aldose reductase inhibitors useful in ophthalmic wound healing will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1741298